Allianz Asset Management GmbH
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 1535323
MUNICH, 2M
Position in CPRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$9,235,207
+$675,100 QoQ
Shares Held
372,989
+1.7% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 29%
Shared 0%
None 71%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Allianz Asset Management GmbH holds $654,142,197 across 68 Biotechnology names. CPRX ranks #14 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
301,196 | $232,716,076 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
610,297 | $115,376,647 | |
| 3 | MRNA |
Moderna, Inc.
|
988,908 | $50,236,526 | |
| 4 | EXEL |
Exelixis, Inc.
|
954,551 | $40,940,690 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
400,020 | $22,597,128 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,441,683 | $20,846,736 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
47,662 | $15,769,925 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
706,664 | $15,730,340 |
All Filings in CPRX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,235,207 | 372,989 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $8,560,107 | 366,757 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $15,719,575 | 797,948 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $22,520,498 | 1,037,811 | Shares | Defined | 2025-07-28 | |
| 2025-03-31 | $16,832,531 | 694,125 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $2,910,342 | 139,451 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $1,549,327 | 77,934 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,431,135 | 92,391 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,561,800 | 97,980 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $994,042 | 59,134 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $691,276 | 59,134 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,266,800 | 94,256 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,135,544 | 370,057 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $7,678,730 | 412,835 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $5,022,995 | 391,504 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $7,287,208 | 1,039,545 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,589,701 | 915,525 | Shares | Defined | 2022-05-13 | |
| 2021-09-30 | $190,434 | 35,931 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $546,054 | 94,966 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||